Patent · US Active

Immunogenic WT-1 peptides and methods of use thereof

US9265816B2 · kind B2 · utility

15Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 10, 2007
Grant dateFeb 23, 2016
Priority date—
Expiry dateFeb 20, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides mutated WT1 peptides SGQAYMFPNAPYLPSCLES (SEQ ID No:41) and QAYMFPNAPYLPSCL (SEQ ID No:42), immunogenic compositions and vaccines comprising same, and methods of treating, reducing the incidence of, and inducing immune responses to a WT1-expressing cancer, comprising same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.